@insightgenetics.com
We offer technologies including a proprietary immuno-oncology platform, custom TMB panels, NGS, whole-exome sequencing services, RNA-seq, and more.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Oncocyte is a leading brand in the field of precision medicine, offering innovative and streamlined solutions for drug discovery and clinical trials. With over a decade of experience, they specialize in molecular and multivariate assay development, providing a range of tissue-based and blood-based technologies. Their comprehensive offerings include a proprietary immuno-oncology platform, custom TMB panels, NGS, whole-exome sequencing services, RNA-seq, targeted PCR panels, and more.
Oncocyte's expertise extends to various areas, including drug development, biomarker-driven clinical trials, and target discovery. They help identify and validate novel targets for diagnostics and therapeutics, utilizing their immuno-oncology assays, NGS subclassification panels, and broad tissue-based capabilities. Their platform-agnostic approach enables them to support all stages of drug development, from early-stage proof-of-concept tests to clinical trial assays and IVD offerings.
Collaborating with Oncocyte's ISO- and CLIA-certified, CAP-accredited lab ensures reliable and accurate processing of clinical trial samples. The lab has been trusted by top diagnostic and pharma companies for clinical trial testing, with extensive experience in FDA and regulatory submissions. Oncocyte is dedicated to unleashing the power of possibilities in precision medicine, providing cutting-edge solutions to accelerate and de-risk biomarker-driven clinical trials
Company Type
Privately Held
Company Size
11-50
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories